485 related articles for article (PubMed ID: 29801576)
1. Implementation of Pharmacogenomics in Everyday Clinical Settings.
Bank PCD; Swen JJ; Guchelaar HJ
Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
Klein ME; Parvez MM; Shin JG
J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
4. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics in practice: a review and implementation guide.
Kabbani D; Akika R; Wahid A; Daly AK; Cascorbi I; Zgheib NK
Front Pharmacol; 2023; 14():1189976. PubMed ID: 37274118
[TBL] [Abstract][Full Text] [Related]
6. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
J Mol Diagn; 2022 Oct; 24(10):1051-1063. PubMed ID: 35931343
[TBL] [Abstract][Full Text] [Related]
7. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
J Mol Diagn; 2023 Sep; 25(9):619-629. PubMed ID: 37419245
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
Barker CIS; Groeneweg G; Maitland-van der Zee AH; Rieder MJ; Hawcutt DB; Hubbard TJ; Swen JJ; Carleton BC
Br J Clin Pharmacol; 2022 Oct; 88(10):4297-4310. PubMed ID: 34907575
[TBL] [Abstract][Full Text] [Related]
10. Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.
B Tata E; A Ambele M; S Pepper M
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32858798
[TBL] [Abstract][Full Text] [Related]
11. Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.
Chumnumwat S; Lu ZH; Sukasem C; Winther MD; Capule FR; Abdul Hamid AAAT; Bhandari B; Chaikledkaew U; Chanhom N; Chantarangsu S; Charoenyingwattana A; Hang TT; Hlaing TM; Htun KS; Jittikoon J; Le L; Mahasirimongkol S; Mohamed Noor DA; Shrestha J; Suwannoi L; Tragulpiankit P; Turongkaravee S; Wattanapokayakit S; Xangsayarath P; Yuliwulandari R; Zain SM; Chantratita W
Public Health Genomics; 2019; 22(3-4):132-139. PubMed ID: 31587001
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
Shahabi P; Dubé MP
Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
[TBL] [Abstract][Full Text] [Related]
13. Personalized medicine into health national services: barriers and potentialities.
Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
Hess GP; Fonseca E; Scott R; Fagerness J
Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
[TBL] [Abstract][Full Text] [Related]
15. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing
Varughese LA; Bhupathiraju M; Hoffecker G; Terek S; Harr M; Hakonarson H; Cambareri C; Marini J; Landgraf J; Chen J; Kanter G; Lau-Min KS; Massa RC; Damjanov N; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
Front Oncol; 2022; 12():859846. PubMed ID: 35865463
[TBL] [Abstract][Full Text] [Related]
16. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
Haufroid V; Picard N
Ther Drug Monit; 2019 Apr; 41(2):121-130. PubMed ID: 30883506
[TBL] [Abstract][Full Text] [Related]
18. Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.
Blagec K; Koopmann R; Crommentuijn-van Rhenen M; Holsappel I; van der Wouden CH; Konta L; Xu H; Steinberger D; Just E; Swen JJ; Guchelaar HJ; Samwald M
J Am Med Inform Assoc; 2018 Jul; 25(7):893-898. PubMed ID: 29444243
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation.
Shue SA; Rowe E; Bell LA; Damush T; DeLong A; Gowan T; Skaar T; Haggstrom D
Pharmacogenomics; 2023 Nov; 24(17):881-893. PubMed ID: 37975236
[No Abstract] [Full Text] [Related]
20. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
Socco S; Wake DT; Lee JC; Dunnenberger HM
Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
